Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Measuring the Clinical Impact of Participating in Pediatric Oncology Trials

FY 2018-19

Summary
My current Master's research project will aim to examine various methodological and ethical questions in pediatric cancer clinical trials. The ethical pursuit of pediatric cancer trials depends on the ability to convey accurate information about risks and the clinical impact associated with study participation. This is of particular concern because children cannot legally consent to participate in clinical research studies and there is an underlying hesitancy to expose vulnerable children to unproven drugs. It also requires selecting treatments for testing that have the greatest prospect of impacting care. However, both of these are greatly challenged by limited systematic evidence about the clinical impact associated with trial participation in pediatric populations. In particular, there is presently no way of telling a guardian and/or prospective child how likely their participation in a trial will lead to major advances in pediatric cancer care. Thus, this project will address this evidence gap. In this study, we will use clinical trial registration records to estimate the proportion of pediatric patients who participate in trials that lead to clinical care. Secondarily, we will probe these type of trials where impact is the greatest and where it is the weakest. This study will serve many implications, especially relating to informed consent, to better estimate the likelihood of a patient's participation meaningfully advancing the care of future patients, and to help clarify what types of pediatric cancer trials are most likely to result in major advances in care.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406333
Name
Oliviero Elisabeth M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Measuring the Clinical Impact of Participating in Pediatric Oncology Trials
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Treatment; Clinical Trials; Drug Development; Ethics And Health; Informed Consent; Oncology; Pediatrics; Research Ethics; Risk Assessment; Systematic Review
Abstract
My current Master's research project will aim to examine various methodological and ethical questions in pediatric cancer clinical trials. The ethical pursuit of pediatric cancer trials depends on the ability to convey accurate information about risks and the clinical impact associated with study participation. This is of particular concern because children cannot legally consent to participate in clinical research studies and there is an underlying hesitancy to expose vulnerable children to unproven drugs. It also requires selecting treatments for testing that have the greatest prospect of impacting care. However, both of these are greatly challenged by limited systematic evidence about the clinical impact associated with trial participation in pediatric populations. In particular, there is presently no way of telling a guardian and/or prospective child how likely their participation in a trial will lead to major advances in pediatric cancer care. Thus, this project will address this evidence gap. In this study, we will use clinical trial registration records to estimate the proportion of pediatric patients who participate in trials that lead to clinical care. Secondarily, we will probe these type of trials where impact is the greatest and where it is the weakest. This study will serve many implications, especially relating to informed consent, to better estimate the likelihood of a patient's participation meaningfully advancing the care of future patients, and to help clarify what types of pediatric cancer trials are most likely to result in major advances in care.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Oliviero, Elisabeth M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~